1 Min Read
Dec 21 (Reuters) - Novartis Ag
* Novartis - signed licensing deal with Sunovion Pharma for US commercial rights to its three treatments for chronic obstructive pulmonary disease Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.